|
Volume 7, Review 41 |
April 1997 |
|
M. Green, D. Olivieri |
|
A new generation of inhalers in a CFC-free future |
|
G. Huchon |
|
Metered dose inhalers past and present: advantages and limitations |
|
H. Matthys |
|
CFCs and their effect on the ozone layer: the Montreal Protocol and consequences for physicians |
|
D. June |
|
Achieving the change: challenges and successes in the formulation of CFC-free MDIs |
|
C. Leach |
|
Safety assessment of the HFA propellant and the new inhaler |
|
E. Bleecker |
|
Clinical reality: the safety and efficacy of the world's first CFC-free MDI |
|
M.R. Partridge |
|
Managing the change: issues for healthcare professionals, physicians and patients |
|
|
General discussion with speakers |